Gastric Ulcers Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Investment for Healthcare Infrastructure
   3. Market Restraints
      1. High Treatment Costs
      2. Adverse Effects of Medications
   4. Market Opportunity
      1. Increase in the Number of Research and Development Activities
   5. Market Trends
      1. Shift towards Precision Medicine
      2. Rising Adoption of Minimally Invasive Procedures
5. MARKET SEGMENTATION
   1. By Drug Class
      1. Proton Pump Inhibitors (PPI)
      2. H2 Antagonists
      3. Antacids
      4. Antibiotics
      5. Cytoprotective Agents
      6. Others
   2. By Diagnosis
      1. Stool Test
      2. Endoscopy
      3. Imaging Tests
      4. CT scan
      5. X-ray
      6. Others
      7. Blood Tests
      8. Others
   3. By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
   4. By End-Users
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
   5. By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
      4. Others
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Allergan (Ireland)
      2. Allergan (Ireland)
      3. AbbVie Inc. (U.S.)
      4. Amgen Inc. (U.S.)
      5. AstraZeneca (U.K.)
      6. Bristol-Myers Squibb Company (U.S.)
      7. Bayer AG (Germany)
      8. Boehringer Ingelheim International GmbH. (Germany)
      9. Dr. Reddy's Laboratories Ltd. (India)
      10. Eli Lilly and Company (U.S.)
      11. F. Hoffmann-La Roche Ltd. (Switzerland)
      12. Gilead Sciences, Inc. (U.S.)
      13. GlaxoSmithKline plc (U.K.)
      14. Hikma Pharmaceuticals PLC (U.K.)
      15. Johnson & Johnson Private Limited (U.S.)
      16. Lupin (India)
      17. Merck & Co., Inc. (U.S.)
      18. Mylan N.V. (U.S.)
      19. Novartis AG (Switzerland)
      20. Pfizer Inc. (U.S.)
      21. Sanofi (France)
      22. Teva Pharmaceutical Industries Ltd. (Ireland)

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Gastric Ulcers market?

The global market of Gastric Ulcers is projected to reach USD 6.96Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Gastric Ulcers market?

The global Gastric Ulcers market has an estimated annual growth rate of 4.3%.

Q.3. What are the recent trends of Gastric Ulcers market?

Shift towards precision medicine and rising adoption of minimally invasive procedures are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Gastric Ulcers?

The major companies profiled in this report include Allergan (Ireland), Allergan (Ireland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH. (Germany), Dr. Reddy's Laboratories Ltd. (India), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Gilead Sciences, Inc. (U.S.), GlaxoSmithKline plc (U.K.), Hikma Pharmaceuticals PLC (U.K.), Johnson & Johnson Private Limited (U.S.), Lupin (India), Merck & Co., Inc. (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Teva Pharmaceutical Industries Ltd. (Ireland)among others.

Q.5. Which is the largest regional market in the Gastric Ulcers?

North America is the largest regional market for Gastric Ulcers.